ALNYLAM PHARMACEUTICALS, INC. (ALNY) › Weighted Average Diluted SharesALNYLAM PHARMACEUTICALS, INC. (ALNY) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2019-12-31: 109.26M2020-12-31: 114.99M2021-12-31: 118.45M2022-12-31: 121.69M2023-12-31: 124.91M2024-12-31: 127.65M2025-12-31: 134.68M134.68M2019-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31134.68M+5.5%2026-02-12From 2025-01-012024-12-31127.65M+2.2%2026-02-12From 2024-01-012023-12-31124.91M+2.6%2026-02-12From 2023-01-012022-12-31121.69M+2.7%2025-02-13From 2022-01-012021-12-31118.45M+3.0%2024-02-15From 2021-01-012020-12-31114.99M+5.2%2023-02-23From 2020-01-012019-12-31109.26M—2022-02-10From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)